NCT04524520

Brief Summary

A novel coronavirus, designated corona virus disease 2019 (COVID-19) has resulted in a Pandemic at the time of writing (27th April) the reported number of confirmed cases exceeding 3 million and over 200000 associated deaths. The burden on global critical care has been considerable. As of 24th April there have been 8752 UK critical care admissions with services under considerable strain, and a mortality rate over 50%. Survivors of critical illness will require significant input. This study will perform mixed methods to provide rich data on risk stratification and recovery from critical illness. Recovery from a novel disease requires documenting and the study reports physical and psychological changes following hospital discharge in survivors. In addition qualitative interviews are being conducted with patients who have survived and been discharged from critical care along with their relatives and treating professionals, to better understand their needs during recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
194

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 5, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 24, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2022

Completed
Last Updated

July 18, 2022

Status Verified

July 1, 2022

Enrollment Period

2 years

First QC Date

August 19, 2020

Last Update Submit

July 15, 2022

Conditions

Outcome Measures

Primary Outcomes (9)

  • Physical

    Chelsea critical care physical assessment tool

    through study completion , an average of 1 year

  • Physical

    Incremental Shuttle Walk Test (ISWT)

    through study completion , an average of 1 year

  • Physical

    1- minute Sit to Stand, Grip strength

    through study completion , an average of 1 year

  • Health Related Quality of life

    Short Form Survey on health related quality of life (SF-12). Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12). The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations). The United States population average PCS-12 and MCS-12 are both 50 points. Higher scores indicate better outcome.

    at 3 months

  • Health Related Quality of life

    Short Form Survey on health related quality of life (SF-36). Scores can range from 0 to 100 and a higher score indicates better outcome.

    at 1 year

  • Psychological

    Depression Test Questionnaire (PHQ-9). Scores range from 1 to 27 and higher scores indicate worse outcome.

    through study completion , an average of 1 year

  • Psychological

    Anxiety Test Questionnaire (GAD-7). Scores range from 0 to 21 and higher scores indicates worse outcome.

    through study completion , an average of 1 year

  • Psychological

    Montreal Cognitive Assessment (MoCA). Scores range from 0 to 30 and higher scores indicate a better outcome.

    through study completion , an average of 1 year

  • Psychological

    Post-traumatic stress disorder (PTSD) Trauma Screening (TSQ). A screening tool with 10 items. If 6 items are endorsed then the outcome is 'positive' for PTSD.

    at 1 year

Secondary Outcomes (3)

  • risk stratification

    through study completion and average of 1 year

  • risk stratification

    through study completion and average of 1 year

  • risk stratification

    through study completion and average of 1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults admitted to hospital with suspected/confirmed COVID-19.

You may qualify if:

  • Adults ≥18 years admitted to ICU with SARS-CoV-2 and survived
  • Relatives or friends and professionals involved in the care of these patients.

You may not qualify if:

  • Patients \<18 years;
  • Patients with a negative test for SARS-CoV-2 or patients not tested due to absence of symptoms;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Luke Hodgson

Worthing, United Kingdom

Location

Study Officials

  • Dr Luke Hodgson

    Western Sussex Hospitals NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2020

First Posted

August 24, 2020

Study Start

May 5, 2020

Primary Completion

May 8, 2022

Study Completion

June 8, 2022

Last Updated

July 18, 2022

Record last verified: 2022-07

Locations